137 related articles for article (PubMed ID: 21048562)
21. [The impact of the case of definition in public health surveillance. Assessment of the number of hepatitis C cases].
Mazurek J
Przegl Epidemiol; 2001; 55(1-2):183-8. PubMed ID: 11556079
[TBL] [Abstract][Full Text] [Related]
22. The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States.
Armstrong GL; Alter MJ; McQuillan GM; Margolis HS
Hepatology; 2000 Mar; 31(3):777-82. PubMed ID: 10706572
[TBL] [Abstract][Full Text] [Related]
23. Ten leading nationally notifiable infectious diseases--United States, 1995.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1996 Oct; 45(41):883-4. PubMed ID: 8927008
[TBL] [Abstract][Full Text] [Related]
24. Alcohol and hepatitis C mortality among males and females in the United States: a life table analysis.
Chen CM; Yoon YH; Yi HY; Lucas DL
Alcohol Clin Exp Res; 2007 Feb; 31(2):285-92. PubMed ID: 17250621
[TBL] [Abstract][Full Text] [Related]
25. Varicella surveillance practices--United States, 2004.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2006 Oct; 55(41):1126-9. PubMed ID: 17060900
[TBL] [Abstract][Full Text] [Related]
26. Active surveillance for acute viral hepatitis in rural villages in the Nile Delta.
Meky FA; Stoszek SK; Abdel-Hamid M; Selim S; Abdel-Wahab A; Mikhail N; El-Kafrawy S; El-Daly M; Abdel-Aziz F; Sharaf S; Mohamed MK; Engle RE; Emerson SU; Purcell RH; Fix AD; Strickland GT
Clin Infect Dis; 2006 Mar; 42(5):628-33. PubMed ID: 16447107
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis C: Part I. Routine serologic testing and diagnosis.
Moyer LA; Mast EE; Alter MJ
Am Fam Physician; 1999 Jan; 59(1):79-88, 91-2. PubMed ID: 9917576
[TBL] [Abstract][Full Text] [Related]
28. Acute hepatitis B among children and adolescents--United States, 1990-2002.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2004 Nov; 53(43):1015-8. PubMed ID: 15525899
[TBL] [Abstract][Full Text] [Related]
29. Risk factors and outcome among a large patient cohort with community-acquired acute hepatitis C in Italy.
Santantonio T; Medda E; Ferrari C; Fabris P; Cariti G; Massari M; Babudieri S; Toti M; Francavilla R; Ancarani F; Antonucci G; Scotto G; Di Marco V; Pastore G; Stroffolini T
Clin Infect Dis; 2006 Nov; 43(9):1154-9. PubMed ID: 17029134
[TBL] [Abstract][Full Text] [Related]
30. Comparison of meningococcal disease surveillance systems - United States, 2005-2008.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 May; 61(17):306-8. PubMed ID: 22552207
[TBL] [Abstract][Full Text] [Related]
31. Reporting of chlamydial infection--Massachusetts, January-June 2003.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2005 Jun; 54(22):558-60. PubMed ID: 15944526
[TBL] [Abstract][Full Text] [Related]
32. Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006-2012.
Suryaprasad AG; White JZ; Xu F; Eichler BA; Hamilton J; Patel A; Hamdounia SB; Church DR; Barton K; Fisher C; Macomber K; Stanley M; Guilfoyle SM; Sweet K; Liu S; Iqbal K; Tohme R; Sharapov U; Kupronis BA; Ward JW; Holmberg SD
Clin Infect Dis; 2014 Nov; 59(10):1411-9. PubMed ID: 25114031
[TBL] [Abstract][Full Text] [Related]
33. Summary report and recommendations of the Expert Working Groups for Strain and Laboratory Surveillance of Hepatitis B Virus and Hepatitis C Virus.
Can Commun Dis Rep; 1999 Oct; 25(20):169-73. PubMed ID: 10575786
[No Abstract] [Full Text] [Related]
34. Incidence trends of viral hepatitis A, B, and C seropositivity over eight years of surveillance in Saudi Arabia.
Memish ZA; Knawy BA; El-Saed A
Int J Infect Dis; 2010 Feb; 14(2):e115-20. PubMed ID: 19540786
[TBL] [Abstract][Full Text] [Related]
35. Summary of notifiable diseases--United States, 2010.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2012 Jun; 59(53):1-111. PubMed ID: 22647710
[TBL] [Abstract][Full Text] [Related]
36. Reassessing provider reporting in the age of electronic surveillance.
Stachel AG; Waechter H; Bornschlegel K; Reddy V; Hanson H; Wen T; Baumgartner J; Balter S
J Public Health Manag Pract; 2014; 20(2):240-5. PubMed ID: 24458313
[TBL] [Abstract][Full Text] [Related]
37. Australia's notifiable diseases status, 2001: annual report of the National Notifiable Diseases Surveillance System.
Blumer C; Roche P; Spencer J; Lin M; Milton A; Bunn C; Gidding H; Kaldor J; Kirk M; Hall R; Della-Porta T; Leader R; Wright P; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
Commun Dis Intell Q Rep; 2003; 27(1):1-78. PubMed ID: 12725505
[TBL] [Abstract][Full Text] [Related]
38. Summary of Notifiable Diseases - United States, 2011.
Adams DA; Gallagher KM; Jajosky RA; Kriseman J; Sharp P; Anderson WJ; Aranas AE; Mayes M; Wodajo MS; Onweh DH; Abellera JP;
MMWR Morb Mortal Wkly Rep; 2013 Jul; 60(53):1-117. PubMed ID: 23820934
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of reporting timeliness of public health surveillance systems for infectious diseases.
Jajosky RA; Groseclose SL
BMC Public Health; 2004 Jul; 4():29. PubMed ID: 15274746
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of Australia's National Notifiable Disease Surveillance System.
Miller M; Roche P; Spencer J; Deeble M
Commun Dis Intell Q Rep; 2004; 28(3):311-23. PubMed ID: 15574055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
